N/A
Completed N=3,098
Monetary Cost of Alzheimer's Disease in China
Source: ClinicalTrials.gov NCT02694445 ↗Enrolled (actual)
3,098
Serious AEs
—
Results posted
May 2020
Primary outcomePrimary: The Annual National Total Socioeconomic Cost for All AD Patients in China — 167.74 billion US$
Summary
The purpose of the study is to estimate the Chinese economic burden in patients with Alzheimer's Disease (AD).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Annual National Total Socioeconomic Cost for All AD Patients in China |
167.74 | — |
Eligibility Criteria
Inclusion Criteria
- New patients who are diagnosed with AD in this investigation or old patients who were diagnosed prior to this investigation were eligible;
- AD diagnosis must meet criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) and the National Institute of Neurologic and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA). The diagnosis should also meet the following: Modified Hachinski Ischemic Scale (MHIS) score≤4, Activity of Daily Living Scale (ADL) score≥23, Geriatric Depression Scale (GDS) score<11. Neuroimaging MRI support AD diagnosis (exist atrophy in medial temporal lobe, white matter lesions score≤2 minutes according to the Fazekas criteria. AD disease classification according to mini-mental state examination (MMSE) scale (for illiterate dementia: mild: 21~24 points; moderate: 11~20 points; severe: 10 points or less; for lettered dementia: mild: 16~19 points; moderate: 8~15 points; severe: 7 points or less). The diagnosis of AD was confirmed by brain CT or MRI scans and by laboratory tests to rule out any other significant comorbidity.
- 60-year-old and above, men or women.
- Normal vision or corrected visual, normal audition or corrected auditory, and cooperate with inspections and treatments.
- Consent to participate with a signed informed consent by himself/herself or guardians.
Exclusion Criteria
- Patient with vascular dementia or dementia caused by other reasons, such as major depression or other major psychiatric illnesses, thyroid dysfunction, encephalitis, multiple sclerosis, and other dementia which includes frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), and Parkinson's dementia (PDD).
- MRI and laboratory tests (blood cell counts, liver and renal function, electrolyte, vitamin B12/folic, HIV, syphilis, and so on) do not support or rule out AD diagnoses.
- Has a history of alcoholism and drug abuse.
Data sourced from ClinicalTrials.gov (NCT02694445). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.